Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sabine Brookman-May, Maximilian Burger, Wolf F Wieland, Wolfgang Rößler, Matthias May & Stefan Denzinger. (2011) Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease. Expert Review of Vaccines 10:6, pages 837-852.
Read now
Read now
Eyad Elkord, Alaaeldin Shablak, Peter L Stern & Robert E Hawkins. (2009) 5T4 as a target for immunotherapy in renal cell carcinoma. Expert Review of Anticancer Therapy 9:12, pages 1705-1709.
Read now
Read now
P J Wysocki, J Zolnierek, C Szczylik & A Mackiewicz. (2007) Recent developments in renal cell cancer immunotherapy. Expert Opinion on Biological Therapy 7:5, pages 727-737.
Read now
Read now
Philip E Shaheen & Ronald M Bukowski. (2005) Emerging drugs for renal cell carcinoma. Expert Opinion on Emerging Drugs 10:4, pages 773-795.
Read now
Read now
Articles from other publishers (18)
J. Guo, G. Li, J. Tang, X.-B. Cao, Q.-Y. Zhou, Z.-J. Fan, B. Zhu & X.-H. Pan. (2013) HLA-A2-restricted Cytotoxic T Lymphocyte Epitopes from Human Hepsin as Novel Targets for Prostate Cancer Immunotherapy. Scandinavian Journal of Immunology 78:3, pages 248-257.
Crossref
Crossref
Su-Tang Lo, Amit Kumar, Jer-Tsong Hsieh & Xiankai Sun. (2013) Dendrimer Nanoscaffolds for Potential Theranostics of Prostate Cancer with a Focus on Radiochemistry. Molecular Pharmaceutics 10:3, pages 793-812.
Crossref
Crossref
Jin Wang, Lianming Liao & Jianming Tan. (2012) Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials. Immunotherapy 4:10, pages 1031-1042.
Crossref
Crossref
Xinji Zhang, Xiaojun Shi, Jinlong Li, Zhiming Hu, Dong Zhou, Jimin Gao & Wanlong Tan. (2012) A Novel Therapeutic Vaccine of Mouse GM-CSF Surface Modified MB49 Cells Against Metastatic Bladder Cancer. The Journal of Urology 187:3, pages 1071-1079.
Crossref
Crossref
Johannes Vieweg. 2012. Renal Cell Carcinoma. Renal Cell Carcinoma
305
322
.
Daniel Laheru. 2011. Principles of Anticancer Drug Development. Principles of Anticancer Drug Development
519
533
.
Osama E Rahma, Ed Ashtar, Ramy Ibrahim, Antoun Toubaji, Barry Gause, Vincent E Herrin, W Marston Linehan, Seth M Steinberg, Frank Grollman, George Grimes, Sarah A Bernstein, Jay A Berzofsky & Samir N Khleif. (2010) A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma. Journal of Translational Medicine 8:1.
Crossref
Crossref
Weihua Yin, Qiushan He, Zhiming Hu, Zhong Chen, Mao Qifeng, Song Zhichun, Qu Zhihui, Nie Xiaoxia, Jinlong Li & Jimin Gao. (2010) A novel therapeutic vaccine of GM-CSF/TNFα surface-modified RM-1 cells against the orthotopic prostatic cancer. Vaccine 28:31, pages 4937-4944.
Crossref
Crossref
Xu-Dong Tang, Guang-Ping Liang, Chuan Li, Ying Wan, Ting Chen, Ling Chen, Song-Tao Yu, Zhen Xiong, Dian-Chun Fang, Guo-Zheng Wang & Shi-Ming Yang. (2010) Cytotoxic T lymphocyte epitopes from human heparanase can elicit a potent anti-tumor immune response in mice. Cancer Immunology, Immunotherapy 59:7, pages 1041-1047.
Crossref
Crossref
Alaaeldin Shablak, Robert E. Hawkins, Dominic G. Rothwell & Eyad Elkord. (2009) T Cell–Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective. Clinical Cancer Research 15:21, pages 6503-6510.
Crossref
Crossref
Yashwant Kumar, Alka Bhatia, Ashim Das & Anjali Solanki Kathpalia. (2009) Unusual Appearance of Perirenal Fibrosis in Renal Cell Carcinoma Simulating a Tumour. Japanese Journal of Clinical Oncology 39:10, pages 677-681.
Crossref
Crossref
Sergei Kusmartsev, Zhen Su, Axel Heiser, Jens Dannull, Evgeniy Eruslanov, Hubert Kübler, Donna Yancey, Philip Dahm & Johannes Vieweg. (2008) Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma. Clinical Cancer Research 14:24, pages 8270-8278.
Crossref
Crossref
Lynn Wenandy, Rikke Bæk Sørensen, Inge Marie Svane, Per thor Straten & Mads Hald Andersen. (2008) RhoC a new target for therapeutic vaccination against metastatic cancer. Cancer Immunology, Immunotherapy 57:12, pages 1871-1878.
Crossref
Crossref
Dan Laheru & Elizabeth M. Jaffee. 2005. The Cancer Handbook. The Cancer Handbook.
Barbara Seliger. (2007) Immune Escape Mechanisms of Renal Cell Carcinoma. European Urology Supplements 6:10, pages 616-622.
Crossref
Crossref
Chie Kudo-Saito, Elizabeth K. Wansley, M. Eilene Gruys, Robert Wiltrout, Jeffrey Schlom & James W. Hodge. (2007) Combination Therapy of an Orthotopic Renal Cell Carcinoma Model Using Intratumoral Vector-Mediated Costimulation and Systemic Interleukin-2. Clinical Cancer Research 13:6, pages 1936-1946.
Crossref
Crossref
Johannes Vieweg. (2006) Future directions for vaccine-based therapies. Urologic Oncology: Seminars and Original Investigations 24:5, pages 448-455.
Crossref
Crossref
A. Haferkamp, D. Rohde, S. C. Müller, H. Rübben & M. Hohenfellner. (2006) Das Nierenzellkarzinom. Der Urologe 45:S04, pages 74-84.
Crossref
Crossref